TNFSF11 and myeloid sarcoma: Osteoclast differentiation is derived by a factor called receptor activator of nuclear factor kappa B ligand (RANKL)14 and significantly higher levels of serum RANKL and osteoprotegrin (OPG) levels were found in the MS patients.15